Hims & Hers Health, Inc.
Hims & Hers Health Announces New Share Repurchase Program
Summary
On November 13, 2025, Hims & Hers Health, Inc.'s Board of Directors authorized a new share repurchase program (the '2025 Share Repurchase Program') allowing the Company to repurchase up to $250.0 million of its Class A common stock. The program, which expires on November 11, 2028, replaces the prior $100.0 million program that was fully utilized from October 1, 2025, through November 7, 2025. Repurchases will be made on a discretionary basis, subject to business and market conditions.
Profitelligence Alerts
Get alerts for HIMS
Be first to know when Hims & Hers Health, Inc. files with the SEC.
Filing Categories
Advertisement
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Official SEC Documents
Advertisement